Related Experiment Video
Updated: Sep 24, 2025

Ultrasound Imaging of the Thoracic and Abdominal Aorta in Mice to Determine Aneurysm Dimensions
Published on: March 8, 2019
Expression of Tissue microRNAs in Ascending Aortic Aneurysms and Dissections
Athina Goliopoulou1, Evangelos Oikonomou1, Alexis Antonopoulos2
13rd Department of Cardiology, National and Kapodistrian University of Athens, Medical School, "Sotiria" Chest Disease Hospital, Athens, Greece.
Abstract:
Little is known about the role of serum and tissue mediators in the progression of ascending aortic aneurysms and dissections. We examined how the tissue expression of microRNAs and matrix metalloproteinases (MMPs), as well as the serum levels of osteoprotegerin, adiponectin, and high sensitivity C-reactive protein (hsCRP) are associated with these entities. We enrolled 21 patients with ascending aortic aneurysm, 11 with acute Stanford type A aortic dissection and 18 controls. The serum levels of osteoprotegerin, adiponectin, and hsCRP, as well as the tissue expression of MMPs 2 and 9 and tissue microRNAs 29 and 195 were compared among groups. There was no difference regarding serum osteoprotegerin, adiponectin, and tissue MMP2 and MMP9 levels. hsCRP was higher in the dissection group (P = .03). Tissue expression of microRNA 29 was 2.11-fold higher in the dissection (P = .001) and 2.99-fold higher in the aneurysm group (P < .001), compared with the control group. Tissue expression of microRNA 195 was 2.72-fold higher in the dissection (P < .001) and 2.00-fold lower in the aneurysm group (P = .08), compared with to the control group. These findings support the contribution of microRNAs in the progression of aneurysm formation and dissection, suggesting a role as potential biomarkers and future therapeutic targets.
Insights
MicroRNAs, not matrix metalloproteinases, are implicated in ascending aortic aneurysms and dissections. Elevated microRNA-29 and microRNA-195 suggest their role in disease progression and potential as therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Aortic Disease Research
Background:
- The molecular mechanisms driving ascending aortic aneurysms and dissections remain incompletely understood.
- Investigating serum and tissue mediators is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To evaluate the association of tissue microRNAs (miRNAs) and matrix metalloproteinases (MMPs) with ascending aortic aneurysms and dissections.
- To assess serum levels of osteoprotegerin, adiponectin, and high sensitivity C-reactive protein (hsCRP) in these conditions.
Main Methods:
- Comparative analysis of serum biomarkers and tissue expression of specific miRNAs and MMPs in patients with aortic aneurysm, aortic dissection, and healthy controls.
- Quantitative assessment of tissue miRNA-29, miRNA-195, MMP-2, and MMP-9 expression.
- Measurement of serum osteoprotegerin, adiponectin, and hsCRP levels.
Main Results:
- Serum levels of osteoprotegerin, adiponectin, and tissue expression of MMP-2 and MMP-9 showed no significant differences between groups.
- Higher hsCRP levels were observed in the aortic dissection group compared to controls.
- Tissue expression of miRNA-29 was significantly elevated in both aneurysm and dissection groups, while miRNA-195 was higher in the dissection group and lower in the aneurysm group compared to controls.
Conclusions:
- MicroRNAs play a significant role in the progression of ascending aortic aneurysms and dissections.
- Specific miRNAs, such as miRNA-29 and miRNA-195, show altered expression patterns in these aortic diseases.
- These findings highlight miRNAs as potential diagnostic biomarkers and therapeutic targets for aortic pathologies.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

